Tumour Growth Causes Suppression of Autoreactive T-Cell Proliferation by Disrupting Macrophage Responsiveness to Interferon-gamma
- 1 January 1994
- journal article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 39 (1) , 31-38
- https://doi.org/10.1111/j.1365-3083.1994.tb03336.x
Abstract
Normal immune homeostasis is regulated partly by a small population of CD4+ T cells that react to autologous major histocompatibility complex class-II molecules on self-cells. Decreased autoreactive T-cell responses are associated with cancer. Tumour growth causes syngeneic macrophages (M phi) to suppress autoreactive T-cell proliferation by decreasing M phi class-II expression and increasing M phi production of the suppressor molecule prostaglandin E2 (PGE2). Because interferon-gamma (IFN-gamma) is a potent M phi activation molecule which regulates both M phi PGE2 and class-II expression, the effects of IFN-gamma on tumour-induced suppression of autoreactive T-cell proliferation were investigated. Exogenous IFN-gamma increased normal host (NH) CD4+ autoreactive T-cell proliferation stimulated by syngeneic NH M phi but decreased proliferation stimulated by tumour-bearing host (TBH) M phi. Antibody (Ab) neutralization of endogenous IFN-gamma activity reduced TBH M phi-mediated suppression. Kinetic studies showed that endogenous IFN-gamma suppressor activity was not exclusive during T-cell activation. Indomethacin treatment blocked IFN-gamma-induced suppression in TBH M phi-T cell cultures. TBH M phi-T cell cultures contained significantly more PGE2 than those containing NH M phi. Exogenous IFN-gamma increased early PGE2 production in TBH M phi cultures but decreased production in NH M phi cultures. The Ab-mediated neutralization of endogenous transforming growth factor-beta or tumour necrosis factor-alpha reduced TBH M phi-mediated suppression and blocked IFN-gamma-induced suppression. Short-term treatment of M phi with IFN-gamma before their addition to T cells caused TBH M phi to stimulate T-cell proliferation, which suggests that early suppressor molecule production by TBH M phi inhibits synthesis or activity of IFN-gamma-induced stimulatory monokines. These results show that tumour growth causes M phi to suppress autoreactive T-cell responses by allowing IFN-gamma to induce M phi suppressor molecules, which block production or activity of stimulatory monokines.Keywords
This publication has 27 references indexed in Scilit:
- Tumor-induced modulation of macrophage class II MHC molecule mRNA expressionMolecular Immunology, 1993
- Tumor-induced alteration in macrophage accessory cell activity on autoreactive T cellsCancer Immunology, Immunotherapy, 1989
- Augmentation of lymphokine-activated killer cell activity in patients with gastrointestinal cancerBritish Journal of Surgery, 1988
- Increased liver chemiluminescence in tumor-bearing miceJournal of Free Radicals in Biology & Medicine, 1985
- Inhibition of Interferon-Gamma May Suppress Allograft Reactivity by T Lymphocytes in Vitro and in VivoScience, 1985
- Effect of prostaglandin E2 on the γ-interferon induction of antigen-presenting ability in P388D1 cells and on IL-2 production by T-cell hybridomasCellular Immunology, 1985
- Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities.The Journal of Experimental Medicine, 1984
- ANTIBODIES TO HUMAN LEUCOCYTE INTERFERONS IN CANCER PATIENTSThe Lancet, 1983
- Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity.The Journal of Experimental Medicine, 1982
- Significance of Self‐Recognition and Interleukin‐2 for Immunoregulation, Autoimmunity and CancerScandinavian Journal of Immunology, 1982